MedPath

Metro International Biotech, LLC

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Tracing the Metabolic Flux of Orally Administered NAD+ Precursors

Phase 1
Recruiting
Conditions
Healthy Adults
Interventions
Drug: Nicotinamide Mononucleotide (NMN)
Drug: Nicotinamide (NAM)
First Posted Date
2025-03-18
Last Posted Date
2025-05-06
Lead Sponsor
Metro International Biotech, LLC
Target Recruit Count
32
Registration Number
NCT06882096
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Brigham and Women's Hospital, Boston, Massachusetts, United States

Phase 1a Single Ascending Dose Study of MIB-725 in Healthy Adults

Phase 1
Recruiting
Conditions
Healthy Adults
Interventions
First Posted Date
2025-02-10
Last Posted Date
2025-02-20
Lead Sponsor
Metro International Biotech, LLC
Target Recruit Count
32
Registration Number
NCT06815991
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Brigham and Women's Hospital, Boston, Massachusetts, United States

Effects of MIB-626 With and Without A High-Intensity Multi-Dimensional Exercise Training Program

Phase 2
Recruiting
Conditions
Healthy
Interventions
Drug: Investigational Product - MIB 626
Drug: Placebo
Other: Usual Physical Activity
Other: Standardized, progressive, high intensity, multidimensional exercise
First Posted Date
2023-05-26
Last Posted Date
2023-11-03
Lead Sponsor
Metro International Biotech, LLC
Target Recruit Count
120
Registration Number
NCT05878119
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Brigham and Women's Hospital, Boston, Massachusetts, United States

Phase 2a MIB-626 vs. Placebo COVID-19

Phase 2
Completed
Conditions
Covid19
Stage 1 Acute Kidney Injury
Interventions
Drug: Placebo
Other: Home Treatment
First Posted Date
2021-09-09
Last Posted Date
2024-08-27
Lead Sponsor
Metro International Biotech, LLC
Target Recruit Count
42
Registration Number
NCT05038488
Locations
๐Ÿ‡บ๐Ÿ‡ธ

The Brigham and Women's Hospital, Boston, Massachusetts, United States

NAD+ Precursor Supplementation in Friedreich's Ataxia

Phase 2
Completed
Conditions
Friedreich Ataxia
Interventions
First Posted Date
2021-03-25
Last Posted Date
2023-07-17
Lead Sponsor
Metro International Biotech, LLC
Target Recruit Count
7
Registration Number
NCT04817111
Locations
๐Ÿ‡บ๐Ÿ‡ธ

The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath